DBTX Annual SG&A
$23.63 M
+$3.24 M+15.91%
31 December 2022
Summary:
As of January 23, 2025, DBTX annual selling, general & administrative expenses is $23.63 million, with the most recent change of +$3.24 million (+15.91%) on December 31, 2022. During the last 3 years, it has risen by +$8.95 million (+60.99%).DBTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Quarterly SG&A
$6.21 M
+$26.00 K+0.42%
30 June 2023
Summary:
As of January 23, 2025, DBTX quarterly selling, general & administrative expenses is $6.21 million, with the most recent change of +$26.00 thousand (+0.42%) on June 30, 2023. Over the past year, it has increased by +$351.00 thousand (+5.99%).DBTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX TTM SG&A
-$1.14 B
-$63.39 M-5.89%
30 June 2023
Summary:
As of January 23, 2025, DBTX TTM selling, general & administrative expenses is -$1.14 billion, with the most recent change of -$63.39 million (-5.89%) on June 30, 2023. Over the past year, it has dropped by -$1.16 billion (-5048.01%).DBTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.9% | +6.0% | -5048.0% |
| 3 y3 years | +61.0% | +143.2% | -10000.0% |
| 5 y5 years | +102.1% | - | -10000.0% |
DBTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -5.2% | -4914.4% |
Decibel Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $6.21 M(+0.4%) | $23.61 M(+1.5%) |
| Mar 2023 | - | $6.19 M(+26.4%) | $23.26 M(-1.5%) |
| Dec 2022 | $23.63 M(+15.9%) | $4.89 M(-22.6%) | $23.63 M(-0.1%) |
| Sept 2022 | - | $6.32 M(+7.8%) | $23.66 M(+2.8%) |
| June 2022 | - | $5.86 M(-10.5%) | $23.02 M(+4.4%) |
| Mar 2022 | - | $6.55 M(+33.1%) | $22.05 M(+8.2%) |
| Dec 2021 | $20.38 M | $4.92 M(-13.3%) | $20.38 M(-0.9%) |
| Sept 2021 | - | $5.68 M(+15.9%) | $20.57 M(+19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $4.90 M(+0.3%) | $17.29 M(+15.7%) |
| Mar 2021 | - | $4.88 M(-4.5%) | $14.95 M(+5.0%) |
| Dec 2020 | $14.24 M(-3.0%) | $5.11 M(+113.2%) | $14.24 M(+14.9%) |
| Sept 2020 | - | $2.40 M(-6.2%) | $12.39 M(+24.0%) |
| June 2020 | - | $2.56 M(-38.8%) | $9.99 M(+34.3%) |
| Mar 2020 | - | $4.18 M(+28.1%) | $7.44 M(+128.1%) |
| Dec 2019 | $14.68 M(+25.5%) | $3.26 M | $3.26 M |
| Dec 2018 | $11.69 M | - | - |
FAQ
- What is Decibel Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Decibel Therapeutics?
- What is Decibel Therapeutics annual SG&A year-on-year change?
- What is Decibel Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly SG&A year-on-year change?
- What is Decibel Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Decibel Therapeutics?
- What is Decibel Therapeutics TTM SG&A year-on-year change?
What is Decibel Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of DBTX is $23.63 M
What is the all time high annual SG&A for Decibel Therapeutics?
Decibel Therapeutics all-time high annual selling, general & administrative expenses is $23.63 M
What is Decibel Therapeutics annual SG&A year-on-year change?
Over the past year, DBTX annual selling, general & administrative expenses has changed by +$3.24 M (+15.91%)
What is Decibel Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of DBTX is $6.21 M
What is the all time high quarterly SG&A for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly selling, general & administrative expenses is $6.55 M
What is Decibel Therapeutics quarterly SG&A year-on-year change?
Over the past year, DBTX quarterly selling, general & administrative expenses has changed by +$351.00 K (+5.99%)
What is Decibel Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of DBTX is -$1.14 B
What is the all time high TTM SG&A for Decibel Therapeutics?
Decibel Therapeutics all-time high TTM selling, general & administrative expenses is $23.66 M
What is Decibel Therapeutics TTM SG&A year-on-year change?
Over the past year, DBTX TTM selling, general & administrative expenses has changed by -$1.16 B (-5048.01%)